HuGE Literature Finder
Records
1
-
4
Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma. Immunological investigations 2021 May 1-11. Farid Ann Abd-Almonem, Afify Nermin Abd-Almaksoud, Alsharnoby Aml Abd-Alhamid, Abdelsameea Eman, Bedair Hanan |
PNPLA3 and HLA-DQB1 polymorphisms are associated with hepatocellular carcinoma after hepatitis C virus eradication. Journal of gastroenterology 2020 Oct . Miki Daiki, Akita Tomoyuki, Kurisu Akemi, Kawaoka Tomokazu, Nakajima Tomoaki, Hige Shuhei, Karino Yoshiyasu, Toyoda Hidenori, Kumada Takashi, Tsuge Masataka, Hiramatsu Akira, Imamura Michio, Aikata Hiroshi, Hayes Clair Nelson, Honda Koichi, Seike Masataka, Akuta Norio, Kobayashi Mariko, Kumada Hiromitsu, Tanaka Junko, Chayama Kazua |
Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy. Journal of the Formosan Medical Association = Taiwan yi zhi 2017 Dec . Chang Kuo-Chin, Ye Yi-Hao, Wu Cheng-Kun, Lin Ming-Tsung, Tsai Ming-Chao, Tseng Po-Lin, Hu Tsung-H |
Association between low molecular polypeptide 7 single nucleotide polymorphism and response to therapy in hepatitis C virus infection. World journal of hepatology 2013 Mar 5 (3): 97-103. Omran Moataza H, Fotouh Basma E, Youssef Samar S, Ibrahim Noha E, Nabil Wael, Mahdy El-Sayed M, Shosha Wafaa G, El-Awady Mostafa |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: